Drug name - Arazlo

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11311482 BAUSCH Topical compositions and methods for treating skin diseases
May, 2038

(15 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) Dec 18, 2022

Drugs and Companies using TAZAROTENE ingredient

Market Authorisation Date: 18 December, 2019

Treatment: Topical treatment of acne vulgaris in patients 9 years of age and older

Dosage: LOTION;TOPICAL

More Information on Dosage
Strength Dosage Availability
0.045% LOTION;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.

Other things you might be interested in